TychoBio is solving RNA therapeutics design by measuring what really matters in unprecedented details. Our lab in the loop platform designs and test antisense oligonucleotides at a high throughput, identifying and pushing the boundaries of design models.
We are interested in partnering with companies working on patient diagnostic and target identification for rare disease, and/or with modified oligonucleotide manufacturers developing cost effective cGMP-grade small scale manufacturing.
Social media
Areas of activity
Next-generation therapeutics and modalities
Innovative cancer treatment modalities
Advanced diagnostics and data technologies
Advanced bioinformatics and artificial intelligence for biotechnology
TychoBio France runs a high-throughput screening platform integrating long-read sequencing and live cell imaging in multiple disease and toxicity relevant cell types, and trains state of the art ASO design and RNA regulation models.